Mylan Investor Relations

Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of approximately 7,500 marketed products around the world, including antiretroviral therapies on which approximately 50% of people being treated for HIV/AIDS in the developing world depend. We market our products in more than 165 countries and territories. We are one of the world's largest producers of active pharmaceutical ingredients. Every member of our more than 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time.

 

Mylan (MYL) NASDAQ | May 26, 2017, 12:35 ET

39.81
- 0.02
Day High: 39.99
Day Low: 39.43
Volume: 1,551,411
52-Week High: 50.40
52-Week Low: 33.60

Events

May
22
UBS Global Healthcare Conference
Location: New York City

May 22, 2017

May
10
First Quarter 2017 Financial Results

May 10, 2017

Mar
14
Barclays Global Healthcare Conference
Location: Miami

March 14, 2017

Leadership

In order to set new standards in healthcare, we have leaders dedicated to helping people gain access to affordable medicine on a global scale. Learn about the passionate people who carry out Mylan’s day-to-day business and bring quality to our facilities.

Mylan will provide shareholders, upon request, a hard copy of its latest 10-K free of charge.